Inter-reader variability of imaging biomarkers for therapeutic response in pancreatic ductal adenocarcinoma.
Jon S. Heiselman(Memorial Sloan Kettering Cancer Center), Jayasree Chakraborty(Memorial Sloan Kettering Cancer Center), Natally Horvat(Alliance Data (United States)), William R. Jarnagin(Memorial Sloan Kettering Cancer Center), Brett L. Ecker(Rutgers, The State University of New Jersey), Richard Kinh Gian(Memorial Sloan Kettering Cancer Center), Kevin C. Soares(Memorial Sloan Kettering Cancer Center), Vinod P. Balachandran(Memorial Sloan Kettering Cancer Center), T. Peter Kingham(Memorial Sloan Kettering Cancer Center), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), Maria El Homsi(Memorial Sloan Kettering Cancer Center), Jeffrey A. Drebin(Memorial Sloan Kettering Cancer Center), Onur Yıldırım(Memorial Sloan Kettering Cancer Center), Alice C. Wei(Université Paris Cité), Burcin Agridag-Upcinar(Memorial Sloan Kettering Cancer Center), Michael I. D’Angelica(Memorial Sloan Kettering Cancer Center)
Cited by 1
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k